CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-25 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −26,198 | $50.07 | $1.3M | 2,918,326 |
| 2026-03-20 | WILSON JAMES N Director | Gift | −4,000 | 1,102,532 | ||
| 2026-03-20 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +11,767 | $21.65 | $255K | 13,998 |
| 2026-03-20 | Guyer William Chief Development Officer | Sale 10b5-1 | −11,767 | $36.01 | $424K | 2,231 |
| 2026-03-20 | Guyer William Chief Development Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −11,767 | 210,000 | ||
| 2026-03-17 | BAKER G LEONARD JR Director | Purchase | +75,782 | $33.00 | $2.5M | 1,122,413 |
| 2026-03-17 | BAKER G LEONARD JR Director | Purchase | +24,218 | $33.56 | $813K | 1,146,631 |
| 2026-03-13 | WILSON JAMES N Director | Gift | −28,000 | 1,106,532 | ||
| 2026-03-13 | MAHONEY DAVID L Director | Option exercise | +30,000 | $5.86 | $176K | 30,000 |
| 2026-03-13 | MAHONEY DAVID L Director | Shares withheld for taxes | −5,469 | $32.15 | $176K | 24,531 |
| 2026-03-13 | MAHONEY DAVID L Director | Gift | −24,531 | 0 | ||
| 2026-03-13 | MAHONEY DAVID L Director | Other acquisition | +24,531 | 1,237,145 | ||
| 2026-03-13 | MAHONEY DAVID L Director | Option exercise · Stock Option (right to buy) | −30,000 | 0 | ||
| 2026-03-04 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +8,233 | $21.65 | $178K | 10,464 |
| 2026-03-04 | Guyer William Chief Development Officer | Sale 10b5-1 | −8,233 | $35.99 | $296K | 2,231 |
| 2026-03-04 | Guyer William Chief Development Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −8,233 | 221,767 | ||
| 2026-03-03 | Lyon Joseph Douglas See Remarks | Shares withheld for taxes | −89 | $35.97 | $3K | 11,230 |
| 2026-03-03 | Maduck Sean See Remarks | Shares withheld for taxes | −110 | $35.97 | $4K | 8,977 |
| 2026-03-03 | Robb Gary Charles Chief Business Officer | Shares withheld for taxes | −121 | $35.97 | $4K | 79,503 |
| 2026-03-03 | Mokari Atabak Chief Financial Officer | Shares withheld for taxes | −96 | $35.97 | $3K | 15,257 |
Page 12 of 61 · 1,220 trades